Table 3.
N (n = 8)d | MC (n = 10) | MDSSG (n = 9)d | P—value | |
---|---|---|---|---|
GLU (mmol/L) | 5.06 ± 0.36 c | 8.13 ± 0.32 a | 7.43 ± 0.22 b | < 0.01 |
TC (mmol/L) | 4.48 ± 0.65 c | 11.49 ± 0.45 a | 6.79 ± 0.53 b | < 0.01 |
TG (mmol/L) | 1.78 ± 0.26 c | 4.47 ± 0.49 a | 2.80 ± 0.36 b | < 0.01 |
GOT (U/L) | 39.12 ± 6.00 b | 77.40 ± 4.93 a | 42.67 ± 5.36 b | < 0.01 |
GPT (U/L) | 41.50 ± 4.52 b | 77.30 ± 4.92 a | 46.22 ± 4.54 b | < 0.01 |
GGT (U/L) | 64.63 ± 6.48 c | 115.30 ± 10.30 a | 75.00 ± 5.22 b | < 0.01 |
SOD (U/mg prot) | 417.39 ± 68.37 a | 214.87 ± 33.21 c | 295.11 ± 54.43 b | < 0.01 |
MDA (nmol/mg prot) | 2.61 ± 0.63 b | 3.97 ± 0.50 a | 3.16 ± 0.68 b | < 0.01 |
Note: If the measured data were normally distributed, the mean ± standard deviation (SD) was used. For the animal experiments, the test data are expressed as the x ± SD, and single factor variance analysis was used to make pairwise comparison among multiple groups.The test level was α = 0.05 and a P-value < 0.05 was considered to be statistically significant. a-c different lower case letters denote a significant difference at P < 0.05 between the different treatment groups. d one rat in the MDSSG group and another one in the normal group have died and were not included into the measurements
GGT γ-glutamyl transpeptidase, GLU glucose, GOT glutamic oxaloacetic transaminase, GPT glutamic-pyruvic transaminase, MC model control group, MDA malondialdehyde, MDSSG Model group treated with DSSG, N normal group, SOD Superoxide dismutase, TC total cholesterol, TCM traditional Chinese medicine, TG triacylglycerol